Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1964054 | Cellular Signalling | 2013 | 9 Pages |
Abstract
Here we report that PLC-β1 catalytic activity plays a role in the increase of cyclin D3 levels and induces the differentiation of C2C12 skeletal muscle cells. PLC-β1 mutational analysis revealed the importance of His331 and His378 for the catalysis. The expression of PLC-β1 and cyclin D3 proteins is highly induced during the process of skeletal myoblast differentiation. We have previously shown that PLC-β1 activates cyclin D3 promoter during the differentiation of myoblasts to myotubes, indicating that PLC-β1 is a crucial regulator of the mouse cyclin D3 gene. We show that after insulin treatment cyclin D3 mRNA levels are lower in cells overexpressing the PLC-β1 catalytically inactive form in comparison to wild type cells. We describe a novel signalling pathway elicited by PLC-β1 that modulates AP-1 activity. Gel mobility shift assay and supershift performed with specific antibodies indicate that the c-jun binding site is located in a cyclin D3 promoter region specifically regulated by PLC-β1 and that c-Jun binding activity is significantly increased by insulin and PLC-β1 overexpression. Mutation of AP-1 site decreased the basal cyclin D3 promoter activity and eliminated its induction by insulin and PLC-β1. These results hint at the fact that PLC-β1 catalytic activity signals a c-jun/AP-1 target gene, i.e. cyclin D3, during myogenic differentiation.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Giulia Ramazzotti, Irene Faenza, Gian Carlo Gaboardi, Manuela Piazzi, Alberto Bavelloni, Roberta Fiume, Lucia Manzoli, Alberto M. Martelli, Lucio Cocco,